Headquarters
San Francisco, CAFounded
2014CEO / Founder
Arif NathooEmployees
501-1000Funding
Series D+ — $514MProducts
1 product listedAvg. AI Score
7.6/10Website
komodohealth.com/Profile updated
Komodo Health was founded in 2014 by Arif Nathoo and Web Sun and is headquartered in San Francisco, California. The company builds a data and technology platform that maps patient care journeys using de-identified real-world healthcare data, aiming to help healthcare organizations identify gaps in care and improve treatment outcomes.
The company's core offering, the Healthcare Map, aggregates clinical, claims, and other healthcare data to support use cases in market access, clinical development, and commercial strategy for pharmaceutical and life sciences companies. Komodo Health serves life sciences companies, payers, and providers, competing with firms such as IQVIA, Truveta, and Datavant in the real-world data and healthcare analytics space.
Komodo Health has raised over $1.3 billion in funding from investors including General Atlantic, Tiger Global, Andreessen Horowitz, and ICONIQ Growth, reaching a valuation of approximately $3.3 billion following a 2021 funding round. The company has made several acquisitions over the years, including Trend Health Partners and Iodine Software's clinical data assets, to expand its data and analytics capabilities.
Dated, source-cited figures. Estimates are marked.
All products by Komodo Health reviewed by our AI panel of experts.
Who Komodo Health competes with, and how they differ.
The incumbent in claims-based real-world data for life sciences, IQVIA sells prescription and patient data alongside a full CRO and commercial-services business, so pharma buyers get trials, consulting and analytics from one vendor. Komodo competes on a single self-serve platform over its own Healthcare Map rather than on syndicated data products and services contracts.
Flatiron builds its real-world evidence from oncology EHR data collected through its own OncoEMR practice network, giving depth in cancer treatment detail Komodo's claims-derived map lacks. Komodo is cross-therapeutic and claims-first, covering 330M+ de-identified patients across all conditions rather than one specialty.
1 product reviewed on TopReviewedTempus pairs its own sequencing lab with clinical records, selling pharma a linked clinico-genomic dataset plus diagnostics revenue. Komodo generates no lab data of its own and competes on breadth of longitudinal claims coverage and the analytics layer on top.
1 product reviewed on TopReviewedPrognos centers on clinical laboratory and diagnostic results as its differentiating real-world data asset, aimed at earlier patient identification for life sciences and payers. Komodo's Healthcare Map is built on medical and pharmacy claims at national scale, with CMS Medicare and Medicaid data added under its Innovator's License.
1 product reviewed on TopReviewedKey milestones in Komodo Health's history, with sources.
Alnylam expanded Marmot deployment across its enterprise
Alnylam Pharmaceuticals extended its use of Komodo's Marmot platform from custom commercial AI agents to its full customer-facing organization and wider enterprise, after reporting that analysis and reporting cycles fell from months to hours.
komodohealth.comLaunched Marmot, a healthcare-native AI engine
Marmot runs analyses against the Healthcare Map's 330 million-plus de-identified patients and ships every result with auditable code reviewed by an independent AI agent. Alnylam Pharmaceuticals signed an enterprise agreement as a launch customer.
komodohealth.comAwarded the CMS Innovator's License
The license lets Komodo Health integrate de-identified Medicare claims, Medicaid claims and Medicare Advantage encounter data covering more than 130 million U.S. beneficiaries into the Healthcare Map alongside its commercial claims data.
komodohealth.comLaunched MapLab
MapLab bundles data science tooling, customizable dashboards and generative AI on top of the Healthcare Map's 330 million-plus de-identified patient journeys, covering disease trends, treatment pathways and patient populations in one offering.
komodohealth.com$200M structured equity from Dragoneer and Coatue amid 9% workforce cut
TechCrunch reported Komodo Health took a $200 million structured equity infusion from Dragoneer and Coatue while cutting 78 roles, about 9% of staff, with its CFO departing at year-end. The company had been valued at $3.3 billion in its March 2021 Series E.
techcrunch.comHired Goldman Sachs and SVB Securities for a planned 2022 IPO
Komodo Health was reported to be preparing a confidential IPO filing with a June or July 2022 listing target, last valued at $3.3 billion with about $150 million in annual recurring revenue. The listing never took place.
pymnts.comAcquired Breakaway Partners
Terms were not disclosed. Breakaway Partners' market-access software tracks formulary changes, medical and pharmacy policy criteria and payer coverage in real time, which Komodo folded into its life sciences offering.
komodohealth.comSeries E — $220M led by Tiger Global
Casdin Capital, ICONIQ Growth, Andreessen Horowitz and SVB Capital participated. Komodo said the Healthcare Map tracked encounters for over 325 million patients across offices in New York City, San Francisco, Silicon Valley, Chicago and Chennai.
komodohealth.comAcquired Mavens, a life sciences cloud software company
Deal terms were not disclosed. Mavens built cloud software for biotech, rare disease and specialty pharma commercialization, extending Komodo beyond data and analytics into enterprise applications.
komodohealth.comSeries D — $44M led by ICONIQ Growth
Andreessen Horowitz, Oak HC/FT, IA Ventures, Felicis Ventures and McKesson Ventures joined the round, which VentureBeat reported took Komodo Health's total funding to $94 million since inception.
venturebeat.comSeries C — $50M led by Andreessen Horowitz
Oak HC/FT, IA Ventures and Felicis Ventures also participated. Komodo said the Healthcare Map then covered over 320 million patients and 15 million new clinical encounters a day, licensed by 70 healthcare organizations including 19 of the top 20 pharmaceutical companies.
komodohealth.comKomodo Health founded by Arif Nathoo and Web Sun
Komodo Health was founded in 2014 to build the Healthcare Map, a de-identified longitudinal view of U.S. patient journeys; co-founder Arif Nathoo, MD serves as CEO and co-founder Web Sun as president. By 2021 the map tracked encounters for more than 325 million patients.
komodohealth.comBrowse multi-perspective AI panel reviews across hundreds of AI tools, agents, and platforms. Find the right software with insights from CTO, Developer, Marketer, Finance, and User perspectives.